MedTrace Logo

Effects of Occlusion Training on Hockey Players

NCT06020729 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-09-01

No results posted yet for this study

Summary

Occlusion training is simply a way of restricting blood flow in the veins of a working muscle in hopes to kick-start some larger gains in muscle size and strength. Occlusion training performed during hockey training on speed and physical performance of hockey players. This training also known as blood flow restriction training, can be defined as the training of muscles while limiting blood flow to the muscles and typically done by performing high intensity, low weight, lifts while using some form of tourniquet or band to limit blood supply to limb being trained.

Conditions

  • Sports Physical Therapy

Interventions

OTHER

General Exercises without occlusion training

General Exercises as bench press, squats , maximum sprint, leg power without occlusion training

OTHER

Occlusion Training

In experimental sessions players will perform with occlusion training which is blood flow resistance training, 4 times a week for 4 weeks with 5 sets of 5 repetitions and then assessed pre-training and post-training values with assessment tools bench press, leg squat, leg power, maximum sprint time.This training will also improve and increase muscular strength as well as speed and physical performance in players.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Amna Shahid, t-DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-25
Primary Completion
2023-09-15
Completion
2023-10-22

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06020729 on ClinicalTrials.gov